Doxorubicin Hydrochloride Injection, Suspension, Liposomal
Product Images NDC 46708-525

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Doxorubicin Hydrochloride (NDC 46708-525). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Alembic Pharmaceuticals Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Doxorubicin-10ml-carton-apl (Doxorubicin 10ml Carton Apl)

Packaging label for doxorubicin hydrochloride liposome injection, 20 mg/10 mL (2 mg/mL) single-dose vial by Alembic Pharmaceuticals Limited. This liposomal formulation is for intravenous infusion after dilution and is cytotoxic. The label includes storage instructions (refrigerate 2° to 8°C, do not freeze) and notes that it is a liposomal formulation not to be substituted for doxorubicin hydrochloride. The vial contains 10 mL of suspension.*

FDA Label Image

Oxorubicin-10ml-vial-apl (Doxorubicin 10ml Vial Apl)

Label for doxorubicin hydrochloride liposome injection, 20 mg/10 mL (2 mg/mL), a cytotoxic intravenous liposomal injection. Manufactured by Alembic Pharmaceuticals Limited in Gujarat, India. The label includes dosage form, strength, storage instructions, and a caution that it is a liposomal formulation and not to substitute for doxorubicin hydrochloride.*

FDA Label Image

Doxorubicin-25ml-carton-apl (Doxorubicin 25ml Carton Apl)

Packaging label for DOXOrubicin Hydrochloride Liposome Injection 50 mg/25 mL (2 mg/mL) by Alembic Pharmaceuticals Limited. The label includes dosage form as injection, suspension, liposomal for intravenous use, storage instructions to refrigerate between 2° to 8°C and not freeze, and a warning that it is a cytotoxic liposomal formulation not for substitution with doxorubicin hydrochloride. The vial size is 25 mL single-dose.*

FDA Label Image

Doxorubicin-25ml-vial-apl (Doxorubicin 25ml Vial Apl)

Label for Doxorubicin Hydrochloride Liposome Injection 50 mg/25 mL (2 mg/mL) in a 25 mL single-dose vial. This intravenous liposomal injection is manufactured by Alembic Pharmaceuticals Limited. The label includes storage instructions to refrigerate at 2° to 8°C and warnings about cytotoxicity and dilution requirements with 5% dextrose injection.*

FDA Label Image

Doxorubicin-figure-1 (Doxorubicin Figure 1)

A survival curve chart depicting percent of subjects progression-free over time (months) comparing two treatment groups: Doxorubicin HCl + Bortezomib versus Bortezomib alone. The y-axis shows percent progression-free, and the x-axis shows time in months up to 15. The graph includes statistical data with a p-value < 0.0001 and hazard ratio (HR) with 95% confidence interval (CI). The number of subjects at risk is shown below for both groups at various time points.*

FDA Label Image

Doxorubicin-hspe (Doxorubicin Hspe)

Chemical structure diagram of doxorubicin hydrochloride, showing detailed molecular bonds and side chains including a choline and phosphate structure with variables m, n indicating chain length.*

FDA Label Image

Doxorubicin-mpeg-dspe (Doxorubicin Mpeg Dspe)

Chemical structure diagram of doxorubicin hydrochloride's liposomal formulation, illustrating the phospholipid components, including a polymer chain denoted as n≈45, phosphatidylcholine backbone with phosphate group, and attached fatty acid chains.*

FDA Label Image

Doxorubicin-pegylated-liposome (Doxorubicin Pegylated Liposome)

An illustration diagram showing the structure of a liposomal drug delivery system for doxorubicin hydrochloride. The diagram labels an outer MPEG-DSPE coating, a liposomal bilayer beneath it, and an aqueous core containing entrapped doxorubicin HCl.*

FDA Label Image

Doxorubicin-structure. (Doxorubicin Structure)

Chemical structure of doxorubicin hydrochloride showing its molecular framework, including aromatic rings, hydroxyl groups, methoxy group, sugar moiety, and the hydrochloride salt representation.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.